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Objective
To compare simultaneous and 2-stage surgical implantation of an artificial urinary sphincter (AUS) and penile prosthesis (PP) for patients with severe urinary incontinence and erectile dysfunction after prostatectomy.
Methods
The data from 23 patients were reviewed, 15 (group 1) underwent simultaneous implantation and 8 (group 2) underwent 2-stage surgery. The operative time, complications, postoperative pain, incidence of pre-and postoperative urinary incontinence, erectile dysfunction rating (International Consultation on Incontinence questionnaire, Incontinence Quality of Life, International Index of Erectile Function, and Erectile Dysfunction Inventory of Treatment Satisfaction), and patient satisfaction were evaluated.
Results
The mean operative time was 140 minutes for the simultaneous procedure (group 1) and 105 minutes for AUS placement and 65 minutes for PP placement (group 2). No major postoperative complications were recorded. The average postoperative hospital stay was 2.5 days after the double-implant procedure and 2.4 days after AUS and 1.2 days after PP placement. The visual analog scale score at 6 and 24 hours after surgery was 5 and 3 in group 1, and 4 and 3 after AUS and 3 and 2 after PP (group 2; P > .05). At 1 year, all patients were socially continent, with an average International Consultation on Incontinence score of 2 in group 1 and 2 in group 2. Of the patients in groups 1 and 2, 65% and 68% were completely dry, respectively (P > .05). The Incontinence Quality of Life score increased from 37 to 84 in group 1 and from 41 to 82 in group 2. The Patient Global Impression of Improvement revealed that 92% of group 1 and 95% of group 2 experienced "great improvement" (P > .05). The International Index of Erectile Function and Erectile Dysfunction Inventory of Treatment Satisfaction score was 70 of 75 and 87 of 100 in group 1 and 72 of 75 and 86 of 100 in group 2, respectively (P > .05). Group 1 patients were completely satisfied, and all group 2 patients stated they would have preferred synchronous surgery.
Conclusion
AUS and PP synchronous placement is feasible and safe and as effective as the 2-stage procedure, with better acceptance by patients.
Urinary incontinence (UI) and erectile dysfunction (ED) are the most frequent complications affecting the prostatectomy outcome. The treatment of patients affected by both UI and ED is a major urologic problem. The therapy of choice is implantation of an artificial urinary sphincter (AUS) for UI and a penile prosthesis (PP) for ED in selected patients not responding to, or not candidates for, other medical or surgical procedures. Few available published studies have demonstrated the feasibility, safety, and cost-effectiveness of dual implantation. Moreover, few have reported encouraging outcomes in functional results and patient satisfaction level.5, 6 and 7 No studies comparing synchronous and delayed implantations of the 2 devices are available.
Our aim was to report our single-center experience comparing simultaneous and 2-stage surgical correction of UI and ED in terms of the surgical feasibility, complications, outcomes, and patient satisfaction.
Material and Methods
We retrospectively reviewed the clinical and surgical documentation of 23 patients (average age 59 years) who had undergone retropubic radical prostatectomy. From January 2005 to February 2011, these same 23 patients sought treatment of severe UI due to sphincter damage and severe ED, not responsive to phosphodiesterase type 5 inhibitors and not responsive or negatively responsive to intracavernous injection therapy. The preoperative evaluation included cystoscopy and urodynamic studies. Cystoscopy was used to ascertain the patency of the urethra and bladderurethral anastomosis.
UI was assessed preoperatively using the International Consultation on Incontinence (ICI) Questionnaire-Urinary Incontinence Short Form,"8 the Incontinence Quality of Life (I-QoL),9 and "social continence" (defined in our study as the use of no pads or ≤1 pad/d). The term "social continence" can be defined as the use of 0, 1, or 2 pads daily, depending on the investigators, but most consider ≤1 pad/d to indicate continence.10 and 11
Sexual dysfunction was determined before surgery using a psychosexual assessment, the International Index of Erectile Function (IIEF), and dynamic Doppler ultrasonography. Sexual dysfunction was assessed 6 months after implantation of the PP using the IIEF and Erectile Dysfunction Inventory of Treatment Satisfaction.
Of the 25 patients, 15 (group 1) underwent simultaneous placement of the AUS and PP (10 patients chose a noninflatable PP and 5 preferred an inflatable PP), and 8 (group 2) underwent deferred surgical correction of UI and ED. Group 2 first underwent implantation of an AUS for severe UI and, in the second stage, underwent implantation of a nonhydraulic malleable PP. The average period between the first and second procedure was 15 months. AUS/PP implantation surgery was performed 10 months (range 8-13) after radical retropubic prostatectomy in both groups.
In the presence of both severe UI and ED, our policy was first to treat the main complaint of the patient, typically the UI. Subsequently, many patients, satisfied by their great improvement in terms of continence, exhorted us to solve their sexual dysfunction and, accordingly, underwent PP implantation. During the same period, 3 other patients were treated. These patients were affected by severe ED and mild or very mild UI and considered sexual impotence to be their main problem after prostatectomy. Thus, as the first procedure, these patients requested PP placement and as the second procedure, AUS implantation. One of these patients underwent concomitant PP and sling implantation, reported unsatisfactory improvement of the UI 13 months after surgery. Two other patients experienced an aggravation of UI, 1 year after PP implantation, because of endoscopic revision of the bladder-urethral anastomosis necessary to treat a stenosis. However, the deferred surgical procedure was easily feasible with no significant difficulties with AUS implantation in patients already having a PP or sling. However, we decided not to include this group of patients because it was not statistically relevant owing to the poor number of cases reported.
Considering the number of patients subsequently undergoing the 2 individual procedures, in accordance with previous data reports,4, 5, 6 and 7 we changed our policy by proposing synchronous PP and AUS implantation in patients affected by both ED and UI.
Considering the preoperative severity of incontinence in our patients, AUS implantation was preferred to a sling, as mentioned in the European Association of Urology guidelines.12 The AMS 800 double-cuff artificial urinary sphincter was implanted in all cases. In all our surgical procedures, an AMS CX 700 was used as a hydraulic PP, and a Subrini Virilis II and an AMS Spectra were implanted as noninflatable PP in 15 and 3 cases, respectively.
Both synchronous implantation of the PP and AUS and implantation of the AUS, as an individual procedure, were performed with the same single transversal scrotal incision. In all procedures, the reservoir of the AUS was located intraperitoneally by a second, small pararectal incision. The reservoir of the hydraulic penile implants was always located extraperitoneally, in the retropubic space, by a single penoscrotal incision, in accordance with the technique of Wilson et al. 4 All patients were extensively informed about the procedures and provided written informed consent for AUS and/or PP implantation.
Postoperative pain was rated using a visual analog score at 6 and 24 hours after each surgical procedure. All patients were evaluated at the 12-month routine follow-up visit after synchronous implantation (group 1) and after the second surgical procedure in group 2. UI was assessed postoperatively using the ICI questionnaire,8 I-QoL,9 and Patient Global Impression of Improvement.13 Postoperative "social continence" was also rated. ED was evaluated using the IIEF questionnaire. Patient satisfaction with PP implantation was assessed using the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire.
The data from the 2 groups was statistically analyzed using the SPSS statistical program with the Wilcoxon and chi-square tests.
Results
The average operative time for the double implantation group (group 1) was 140 minutes. The average operative time was 155 minutes (range 140-180) to implant an inflatable PP and 130 minutes (range 120-150) to implant a malleable PP. In group 2, the average operative time was 105 minutes (range 95-120) for the AUS and 65 minutes (range 60-80) for the PP (all were nonhydraulic implants).
No major intraoperative complications (ie, bleeding, urethral injury, apex or crura perforation) were recorded in either group.
In group 1, the average postoperative hospital stay was 2.5 days. In group 2, the average postoperative stay was 2.4 days after AUS implantation and 1.2 days after PP implantation. We did not find any statistically significant differences in the postoperative hospital stay between the 2 groups.
The average postoperative pain as assessed using the visual analog scale at 6 and 24 hours postoperatively was 5 and 3 in group 1 and 4 and 3 after AUS and 3 and 2 after PP implantation in group 2, respectively. The difference in the subjective assessment of pain using the visual analog scale between the 2 groups was not statistically significant (P > .05).
The average preoperative ICI score was 20 (range 14-21) in group 1 and 18 (range 17-20) in group 2. At the 1-year postoperative follow-up visit, all patients were socially continent, with an average ICI score of 2 (range 1-5) in group 1 and 2 (range 1-4) in group 2. Moreover, 65% and 68% of patients were completely dry in groups 1 and 2, with no significant difference between the 2 groups (P > .05).
The average preoperative I-QoL score was 37 (range 27-51) in group 1 and 41 (range 31-55) in group 2 (P = .243). At 1 year after surgery, the postoperative I-QoL score was 84 (range 72-89) in group 1 and 82 (range 69-88) in group 2, with no meaningful difference between the 2 groups (P = .533).
Our data have suggested that the results in terms of improvement of quality of life are not significantly different whether the UI and ED devices were surgically placed in a simultaneous procedure or a 2-stage procedure.
On the PGI-I, the patients reported experiencing "great improvement" in 92% in group 1 and 95% in group 2 at 3 months after surgery. The difference was not statistically significant (P > .05). The remaining 8% of patients in group 1 and 5% in group 2 considered themselves to have significant improvement (P > .05).
All patients reported excellent sexual improvement. The IIEF (all domains) and Erectile Dysfunction Inventory of Treatment Satisfaction score was 70 of 75 and 87 of 100 in group 1 and 72 of 75 and 86 of 100 in group 2, respectively, with no statistically significant differences (P > .05) between the 2 groups.
All group 1 patients were completely satisfied with the single procedure for both their UI and their ED. All patients in group 2 would have chosen a single procedure for correction of both problems if asked again.
One patient in group 1, who had previously undergone salvage external beam radiotherapy for local recurrence of prostate cancer, experienced a sphincter infection after 2 urethrotomies performed for recurrent urethral stricture. The 2 devices were surgically removed 1.5 years after dual implantation (grade IIIa). No major postoperative complications were detected in group 2.
Comment
Some investigators have defined the goals of radical prostatectomy as a "trifecta," including in the definition long-term cancer control and recovery of sexual and urinary function. Although the incidence of ED and UI has generally decreased, they remain the most defying long-term complications of radical prostatectomy.14, 15, 16 and 17 Prosthetic surgery can effectively treat both conditions and represents an additional chance to obtain the trifecta.18
Currently, the placement of a PP is widely considered an effective and safe procedure to regain sexual satisfaction in patients with iatrogenic erectile dysfunction not responding to medical therapy or for patients or unwilling to use medical therapy.1, 2 and 19
The management of UI is more controversial.2, 20 and 21 The European Association of Urology Guidelines12 consider AUS placement, after a period of conservative management of 6-12 months, as the treatment of choice and the reference standard for intermediate to severe postprostatectomy UI. In contrast, the male sling, considered by some investigators as a satisfactory treatment of postprostatectomy UI,22 and 23 has been deemed by the European Association of Urology guidelines as an alternative exclusively for mild to moderate UI.
The urinary sphincter has been widely used to treat UI after prostatectomy, with a satisfaction rate of ≤90% and total continence rates of approximately 30%.3, 4 and 24
In 1993, Brito et al25 proposed the placement of a second cuff to achieve better outcomes in social continence with excellent results. In a recent report, O'Connor et al26 compared single versus double-cuff AUS implantation, with a significantly greater rate of complete continence and improvement in the Incontinence Impact Questionnaire 7 in men with the double-cuff AUS compared with single-cuff devices. Placing a double-cuff AUS is safe and effective in the treatment of severe postprostatectomy UI,27 with only a slight increase in the operative time. This procedure is standard in our center.
The main unsolved problem regarding the management of both ED and UI after prostatectomy is whether it is better to treat both conditions in a single surgical procedure or in a 2-stage fashion.
Some investigators have suggested treating UI and ED using sling implantation and a PP. In 2005, Rhee28 described a technique for concomitant implantation of an inflatable and semirigid PP with the synthetic male sling, with a high rate of patient satisfaction. Gorbatiy et al29 recently proposed synchronous implantation of an inflatable PP and a bulbourethral sling using a single perineal incision, with satisfactory results. The synchronous placement of the 2 devices does not present with particular surgical difficulties. As expected, a slightly longer operative time results when positioning an inflatable PP but always within the times considered safe regarding the risk of infection. The postoperative pain was only slightly greater 6 hours after double implantation compared with AUS implantation alone, and the average visual analog scale score was the same after 24 hours.
The incidence of surgical site and prosthesis infections and other complications did not increase. The only case of late (1.5 years) infection of the AUS occurred after an endoscopic procedure in a patient in group 1, and it did not seem likely that is was related to the concomitant placement of the 2 devices.
The functional results at 1 year of follow-up in social/complete continence and as evaluated by validated questionnaires do not show statistically significant differences between the single-stage and 2-stage procedures. Moreover, when asked, our patients preferred the single-stage surgery for the correction of both problems. Even the patients who had undergone a 2-stage procedure, when interviewed, would have preferred the single procedure with double implantation.
Conclusion
Our data suggest that dual implantation of a PP and an AUS does not result in a greater incidence of intra-or postoperative complications, is well tolerated, has the same long-term functional outcomes of traditional 2-stage surgery, and, furthermore, is much preferred by the patient. PP and AUS synchronous placement is a safe, highly satisfactory, and cost-effective surgery to treat patients affected by both ED and severe UI after radical prostatectomy, allowing the avoidance of multiple procedures and double anesthesia.
